CIK 0001232524 · Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- EIN
- 981032470
- Phone
- 353-1-634-7800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-05 | Patil Neena M Chief Legal Officer (CLO) and | Shares withheld for taxes | −1,228 | $153.96 | $189K | 32,973 |
| 2022-03-05 | Iannone Robert EVP, Global Head of R&D and Ch | Shares withheld for taxes | −1,327 | $153.96 | $204K | 39,257 |
| 2022-03-05 | GALA RENEE D EVP & CFO | Returned to the company | −720 | $153.96 | $111K | 36,628 |
| 2022-03-05 | COZADD BRUCE C Chairman & CEO | Shares withheld for taxes | −21,929 | $153.96 | $3.4M | 345,846 |
| 2022-03-03 | Tovey Christopher J. EVP & Chief Operating Officer | Grant or award | +7,820 | 16,936 | ||
| 2022-03-03 | Swisher Daniel N JR President and COO | Grant or award | +13,507 | 62,053 | ||
| 2022-03-03 | Sablich Kim EVP & GM, North America | Grant or award | +9,953 | 31,088 | ||
| 2022-03-03 | Pearce Samantha SVP, Head of Europe & Interna | Grant or award | +3,839 | 15,797 | ||
| 2022-03-03 | Patil Neena M Chief Legal Officer (CLO) and | Grant or award | +8,886 | 34,201 | ||
| 2022-03-03 | Larkin Finbar SVP, Technical Operations | Grant or award | +4,621 | 21,209 | ||
| 2022-03-03 | Iannone Robert EVP, Global Head of R&D and Ch | Grant or award | +11,374 | 40,584 | ||
| 2022-03-03 | GALA RENEE D EVP & CFO | Grant or award | +11,730 | 37,348 | ||
| 2022-03-03 | COZADD BRUCE C Chairman & CEO | Grant or award | +44,788 | 367,775 | ||
| 2022-03-03 | Carr Patricia SVP, Chief Accounting Officer | Grant or award | +2,488 | 8,296 | ||
| 2022-03-02 | COZADD BRUCE C Chairman & CEO | Sale | −6,000 | $150.00 | $900K | 322,987 |
| 2022-03-01 | COZADD BRUCE C Chairman & CEO | Option exercise | +9,700 | $46.83 | $454K | 335,488 |
| 2022-03-01 | COZADD BRUCE C Chairman & CEO | Sale | −3,260 | $135.73 | $442K | 332,228 |
| 2022-03-01 | COZADD BRUCE C Chairman & CEO | Sale | −3,041 | $136.73 | $416K | 329,187 |
| 2022-03-01 | COZADD BRUCE C Chairman & CEO | Sale | −200 | $137.40 | $27K | 328,987 |
| 2022-03-01 | COZADD BRUCE C Chairman & CEO | Option exercise · Non-Qualified Stock Option (right to buy) | −9,700 | 48,432 |
Page 29 of 31 · 614 trades